检索
AI 对话
AI 辅写
analysis
趋势分析
编组
数据平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

92P Safety of liver resection following atezolizumab plus bevacizumab treatment in hepatocellular carcinoma (HCC) patients with macrovascular invasion: A pre-specified analysis of the TALENTop study

H. Sun, F. Shen, X. Bai,L-X. Liu,B-D. Xiang, T. Song,M. Chen,M. Kuang,Z-Y. Huang,D. Li, T. Wen,H-T. Zhao,Y-Y. Zeng, X. Zhu, J. Zhou, J. Fan

Annals of Oncology（2022）

引用 0|浏览7
暂无评分
关键词
hepatocellular carcinoma,bevacizumab treatment,liver resection,macrovascular invasion,atezolizumab,pre-specified
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要